Past Projects
We have a proven track record of assisting companies to raise capital and go public. Our principals have over 30+ years of experience in the capital markets and the following are some of our past projects that we took public.
Aydon Income Properties, Inc.
Aydon is a real estate investment and development company targeting under-valued income producing properties in select areas of the United States and Canada with the goal of securing high cash flow and capital appreciation potential in order to provide maximum returns for it’s shareholders and investors. The company is strategically positioned to take advantage of the recovery currently underway in the United States after the historic financial crisis that led to a severe downturn in the residential housing market. Their aim is to capitalize on the recovery in the real estate market by acquiring quality assets at prices below replacement cost in prime residential neighborhoods that can be turned around or made more profitable through rehabilitation and marketing programs designed to maximize occupancy and boost rents.
Certive Solutions Inc.
The company provides cloud revenue cycle management solutions to U.S. hospitals, delivered collaboratively, utilizing proprietary workflow and analytics technologies tailored to health care business processes. Certive is focused on becoming a significant competitor in revenue cycle management for U.S. hospitals, with a goal to acquire customers via asset acquisition of Tier 3 players and to provide technology that scales operations, improves efficiencies, and enhances value for clients. Billing, auditing, and collection of claims is a complicated process involving large quantities of data. Skilled labor will always be part of the operational component of these services, but operational efficiency is a critical success factor to drive improved margins, scalability for growth, and the delivery of a differentiating value proposition for clients. Analytical capabilities are also increasing in importance. Certive is currently investing in software and workflow tools to address these needs and initial implementation.
Network Oncology Inc.
Network Oncology is an emerging specialty pharmaceutical company that has reverse engineered the traditional pharmaceutical business model. The company is committed to forming strategic alliances with governments, NGOs, clinical organizations and oncology professionals to deliver uncompromised quality, and improved healthcare outcomes through the sale of onco-generic drugs. The company is dedicated to serving the oncology market place. By understanding its customer and the market it has the unique ability to serve the oncology segment.
Pivotal Therapeutics Inc.
The company is a specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. Pivotal developed its lead product VASCAZEN® based on the scientific evidence on the benefits of Omega-3 for cardiovascular patients. VASCAZEN® is currently available in the U.S. as a prescription only medical food specifically formulated for the dietary management of Omega-3 Deficiency (OM3D) in patients with cardiovascular disease (CVD). VASCAZEN® results were achieved with a dose of three grams of EPA and DHA per day of a prescription grade, high purity Omega-3 formulation. Pivotal’s second product, OMAZEN® is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of good health. The unique formulation and dosage is available for sale to consumers who realize the health benefits of high purity Omega-3 supplementation.
Silk Road Finance Inc.
Silk Road is an investment group with operations in Mongolia, Myanmar, Mozambique and other catalyst-driven frontier markets. The Group provides investment management, merchant banking, strategic advisory and other financial services to a diverse group of international and regional investors. Eurasia Capital, the Group’s subsidiary in Mongolia is a leading, award-winning investment bank providing capital raising, cross border M&A advisory, sales & trading and research services to its local, regional and international clients. Mandalay Capital is an investment banking advisory subsidiary, offering corporate finance and advisory services to Myanmar companies as well as international and Asian strategic and financial investors seeking investment opportunities in Myanmar. Silk Road Management, the Group’s asset management arm focused on early frontier markets globally. The Firm has recently launched Silk Road M3 Fund to invest in Myanmar, Mongolia and Mozambique, three resource-rich countries which Silk Road believes would be among the world’s top five fastest growing economies in the next decade. Africa Asia Capital is Silk Road Finance’s new corporate finance advisory subsidiary with focus on Mozambique. The Firm intends to facilitate investment flows from major Asian economies (such as China, India, Japan, Korea, Thailand) and Gulf states into Mozambique and other dynamically growing African countries.